Cramer Raises Three Key Questions Ahead of Anthropic IPO, Takes Wait-and-See Stance
nashnova research
Anthropic plans to start trading on November 19 at a fully diluted valuation of up to $1.405 trillion, but CNBC's Jim Cramer says he is in no rush to buy on day one — he flags three unresolved uncertainties, each bearing directly on whether that price tag holds up.
After the price cuts, can revenue keep growing?
Anthropic recently cut prices on several Claude models, raising concerns that customers are turning cost-sensitive or switching to cheaper alternatives.
Cramer acknowledges that October revenue growth stayed strong even after the cuts — an encouraging sign. This means → in the short term, lower prices drove enough extra volume to keep total revenue intact.
But his real question is what happens over the next few months. Surcharges for faster processing speeds may partly offset the cuts, but that mechanism is still unproven.
Where does the next hundred billion in revenue come from?
Anthropic's explosive growth currently hinges on a single product — Claude Code, an AI coding agent for enterprises that helps developers write and debug software.
Cramer's challenge is blunt: can one product sustain the growth needed to cover roughly $900 billion in future compute commitments? In plain terms = the spending is locked in, but the revenue funnel is still narrow.
The company has launched Claude Cowork — an industry-specific toolset aimed at competing with Microsoft Office — and is eyeing cybersecurity, life sciences, and robotics. But all of these are still in early stages, far from generating meaningful revenue.
AI safety pledge — moat or constraint?
Anthropic brands itself around "responsible AI development." CEO Dario Amodei has publicly warned about the risks of powerful models.
Cramer reads this both ways: if the safety commitment slows the release of advanced models, revenue growth could stall. This means → "safety first" sounds noble, but Wall Street grades on quarterly numbers.
The flip side: as enterprises grow more cautious about autonomous AI, a safety-first positioning could become a competitive edge — the question is when that card actually pays off.
A $1.4 trillion valuation — what will prove it right?
The IPO plans to offer 825 million shares at a price range of $70 to $78 per share, raising up to roughly $64.35 billion at the top end, for a fully diluted valuation of up to $1.405 trillion.
Cramer's stance is clear: "For the time being, all I can tell you is I'm wary of it." This reflects a veteran market commentator's instinct when facing sky-high AI valuations — look before you leap.
In plain terms = whether these three questions get answered in post-IPO earnings reports is the real test of whether the valuation holds. There is no rush to chase it on day one.
市场有风险，内容仅供研究参考，不构成投资建议。